Literature DB >> 7241036

Relationship between response rate and reinforcement frequency in variable-interval schedules: III. The effect of d-amphetamine.

C M Bradshaw, H V Ruddle, E Szabadi.   

Abstract

Four rats were exposed to variable-interval schedules specifying a range of different reinforcement frequencies. The effects of two doses of d-amphetamine (1.6 and 3.2 mumol/kg) upon performance maintained under each schedule were examined. In the case of each rat, the response rates observed under control conditions (no injection or injection of the vehicle alone) were increasing, negatively accelerated functions of reinforcement frequency, the data conforming closely to Herrnstein's (1970) equation. In each rat, d-amphetamine (3.2 mumol/kg) significantly reduced the value of the constant Rmax, which expresses the theoretical maximum response rate. In each rat, the value of KH, which expresses the reinforcement frequency needed to obtain the half-maximal response rate, was also reduced, although this only achieved statistical significance in the case of one rat. When the proportional change in response rate in the presence of the drug was plotted against the response rate under control conditions on double logarithmic co-ordinates, linear functions of negative slope were obtained; in each rat the slope was steeper and the value of the control response rate at which d-amphetamine exerted no effect was lower in the case of the higher dose (3.2 mumol/kg) than in the case of the lower dose (1.6 mumol/kg).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7241036      PMCID: PMC1333050          DOI: 10.1901/jeab.1981.36-29

Source DB:  PubMed          Journal:  J Exp Anal Behav        ISSN: 0022-5002            Impact factor:   2.468


  18 in total

Review 1.  Rate-dependent effects of drugs: a review of the literature.

Authors:  D J Sanger; D E Blackman
Journal:  Pharmacol Biochem Behav       Date:  1976-01       Impact factor: 3.533

2.  Statistical estimations in enzyme kinetics.

Authors:  G N WILKINSON
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857

3.  On the law of effect.

Authors:  R J Herrnstein
Journal:  J Exp Anal Behav       Date:  1970-03       Impact factor: 2.468

4.  Relationship between response rate and reinforcement frequency in variable-interval schedules: the effect of the concentration of sucrose reinforcement.

Authors:  C M Bradshaw; E Szabadi; P Bevan
Journal:  J Exp Anal Behav       Date:  1978-05       Impact factor: 2.468

5.  Behavior of humans in variable-interval schedules of reinforcement.

Authors:  C M Bradshaw; E Szabadi; P Bevan
Journal:  J Exp Anal Behav       Date:  1976-09       Impact factor: 2.468

6.  A detailed analysis of the effects of d-amphetamine on behavior under fixed-interval schedules.

Authors:  M N Branch; L R Gollub
Journal:  J Exp Anal Behav       Date:  1974-05       Impact factor: 2.468

7.  Amphetamine and operant behavior in rats: relationship between drug effect and control response rate.

Authors:  T G Heffner; R B Drawbaugh; M J Zigmond
Journal:  J Comp Physiol Psychol       Date:  1974-06

8.  Effects of d-amphetamine on performance under several parameters of multiple fixed-ratio, fixed-interval schedules.

Authors:  D E McMillan
Journal:  J Pharmacol Exp Ther       Date:  1969-05       Impact factor: 4.030

9.  Separating the effects of response rate and reinforcement frequency in the rate-dependent effects of amphetamine and scopolamine on the schedule-controlled performance of rats and pigeons.

Authors:  R C MacPhail; L R Gollub
Journal:  J Pharmacol Exp Ther       Date:  1975-08       Impact factor: 4.030

10.  Chlorpromazine and amphetamine effects on three operant and on four discrete trial reinforcement schedules.

Authors:  O S Ray; L W Bivens
Journal:  Psychopharmacologia       Date:  1966
View more
  17 in total

1.  The sensitivity of response rate to the rate of variable-interval reinforcement for pigeons and rats: a review.

Authors:  Richard L Shull
Journal:  J Exp Anal Behav       Date:  2005-07       Impact factor: 2.468

2.  Interaction between antidepressants and d-amphetamine on variable-interval performance.

Authors:  K Shah; C M Bradshaw; E Szabadi
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  The isolation of motivational, motoric, and schedule effects on operant performance: a modeling approach.

Authors:  Ryan J Brackney; Timothy H C Cheung; Janet L Neisewander; Federico Sanabria
Journal:  J Exp Anal Behav       Date:  2011-07       Impact factor: 2.468

4.  DSP4 alters the effect of d-amphetamine on variable-interval performance: analysis in terms of Herrnstein's equation.

Authors:  M J Morley; C M Bradshaw; E Szabadi
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Chlorpromazine and pimozide alter reinforcement efficacy and motor performance.

Authors:  G M Heyman; D L Kinzie; L S Seiden
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  The effect of pimozide on variable-interval performance: a test of the 'anhedonia' hypothesis of the mode of action of neuroleptics.

Authors:  M J Morley; C M Bradshaw; E Szabadi
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Effects of d-amphetamine on responding under second-order schedules of reinforcement with paired and nonpaired brief stimuli.

Authors:  S L Cohen
Journal:  J Exp Anal Behav       Date:  1991-09       Impact factor: 2.468

8.  Control rate of response or reinforcement and amphetamine's effect on behavior.

Authors:  I Lucki; R E DeLong
Journal:  J Exp Anal Behav       Date:  1983-09       Impact factor: 2.468

9.  A parametric evaluation of the hedonic and motoric effects of drugs: pimozide and amphetamine.

Authors:  G M Heyman
Journal:  J Exp Anal Behav       Date:  1983-09       Impact factor: 2.468

10.  A pharmacological examination of the resistance-to-change hypothesis of response strength.

Authors:  S L Cohen
Journal:  J Exp Anal Behav       Date:  1986-11       Impact factor: 2.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.